Octant on Building Agentic Frontier Drug Hunters with AI
rbhar90 · x · 2026-09-25
Octant Bio publishes "Mens et Manus" on how AI agents are reshaping its drug discovery pipeline. It opens with a thought experiment—would MIT's 1860s founders with unmetered intelligence but period-only knowledge have built a transistor?—arguing agents amplify domain knowledge rather than replace it, and details how Octant builds agentic "drug hunters" around this philosophy.
Related event: Octant Essay: AI Agents Reshape Drug Discovery(2 posts)→
More from Research
- Question's Gambit tops BrowseComp-Plus recall with 96.6% using only BM25 — CShorten30 · 2026-09-25
- ICLR page-limit tip: use \textbf instead of \paragraph to save space — jindong_wang92 · 2026-09-25
- AutoScientists NeurIPS paper: self-organizing AI research teams hit 74.4 percentile on BioML-Bench — marinkazitnik · 2026-09-25
- Does the curse of multilinguality have to exist in theory? Embedding-space study — mdredze · 2026-09-25
- From VPG to GRPO: the clean evolution of RL algorithms behind LLM training — cwolferesearch · 2026-09-25
- MechReason: a 12k-QA benchmark exposing multimodal models' mechanical engineering reasoning gap — AndrewDai · 2026-09-25